The vaccine developed by Pfizer and BioNTech protects against a highly contagious strain of coronavirus that originated in South Africa and the U.K., according to a study published Thursday.
The study, which was commissioned by Pfizer, is likely to alleviate some fears that the virus variant would evade protections offered by the vaccine. Read More
The Trump Administration has purchased an additional 100 million doses of Pfizer’s coronavirus vaccine, the drugmaker announced Wednesday.
The new agreement means that Pfizer will supply 200 million doses to the United States, according to the company’s statement, which will be distributed through July 2021. Also included in the deal is the option to purchase an additional 400 million doses. Read More
The Tennessee Department of Health is setting aside a portion of its COVID-19 vaccines for communities that are poorer and have more people of color, but one minority leader says that is not good enough.
After this current first phase, the state will reserve 5 percent of the vaccine for areas that are poorer and have higher numbers of minorities, CBS News reported. Read More
Few people realize that the Moderna vaccine against COVID-19—which the FDA has finally declared “highly effective,” and which is now being distributed to Americans—has actually been available for nearly a year.
But the government wouldn’t let you take it. Read More
The two coronavirus vaccines that have been approved for emergency use authorization in the U.S. will be able to combat a new, more contagious strain of the virus in the U.K., experts said Monday.
Vaccines made by pharmaceutical companies Pfizer and Moderna will be effective against the new strain, which is “very similar” to previous strains at the genetic level, University of Washington’s Institute for Health Metrics and Evaluation affiliate assistant professor Vin Gupta told CNBC. The Food and Drug Administration has approved both vaccines for emergency use authorization after large-scale human trials showed efficacy of more than 90%. Read More
The nurse who appeared to faint after receiving a COVID-19 vaccine in a viral video has recovered, according to a statement issued by her employer. Tiffany Dover, a nurse at CHI Memorial Hospital, reportedly came close to passing out due to a medical condition unrelated to the vaccination.
The hospital also cited information from the Centers for Disease Control (CDC) website, which stated that fainting sometimes occurs after all types of vaccinations. Read More
Some vials containing Pfizer’s coronavirus vaccine contain more doses than expected, potentially expanding the country’s supply by up to 40%, public health officials said late Wednesday.
The FDA advised that the extra doses were acceptable to use and that it was collaborating with Pfizer over the issue. Read More
Governor DeWine unexpectedly called a press conference on Monday. It was the day the Pfizer vaccine arrived in Ohio and DeWine called it “historic,” our “hope” and the “beginning of the end” of COVID. A video of he and First Lady Fran DeWine can be viewed below as the… Read More
Tuesday morning on the Tennessee Star Report, host Michael Patrick Leahy welcomed all-star panelist Clint Brewer to the studio to discuss the proposed rollout of the new COVID-19 vaccine. Read More
Pfizer CEO Albert Bourla said on CNN Monday that the U.S. is seeking to double its COVID-19 vaccine order.
“So far, we have an agreement with the U.S. Government to provide them 100 million doses and this is a fixed order and we will provide those 100 million doses starting from now by the end of the first quarter and we will honor this commitment,” Bourla told CNN Chief Medical Correspondent Dr. Sanjay Gupta on “New Day With Alisyn Camerota and John Berman.” Read More
Video footage showed the first shipment of the coronavirus vaccine leaving Pfizer’s Michigan location on Sunday.
UPS, Boyle and FedEx trucks were captured on video leaving the facility located close to Kalamazoo, Michigan. Read More
With COVID-19 vaccines expected in states throughout the country next week, some communities need more than others, according to a recently released study, and Ohio is home to three of those cities.
According to the personal finance website WalletHub, Cleveland, Toledo and Cincinnati rank among the top 10 of 90 large cities in the United States in terms of vaccine need based on 13 key factors, such as frontline healthcare workers, nursing home residents, essential workers, residents diagnosed with various diseases and other things. Read More
Britain’s National Health Service administered its first doses of a coronavirus vaccine Tuesday, becoming the first country to begin its mass vaccination effort.
Just after 6:30 a.m. Tuesday, 90-year-old Margaret Keenan became the first person to receive a fully authorized vaccine outside of a clinical trial, marking the beginning of a global campaign to end a pandemic that has infected over 65 million people and killed over 1.5 million across the globe. Read More
The Virginia Department of Health (VDH) announced on Friday that the Commonwealth is preparing to receive 480,000 doses of COVID-19 vaccine by the end of December based on new information from the federal government’s Operation Warp Speed.
As Governor Ralph Northam noted during a coronavirus briefing on Wednesday, the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted last week to officially recommend healthcare personnel and long-term care facility residents as top priority for vaccination. Read More
Virginia Governor Ralph Northam said that initial doses of Pfizer’s COVID-19 vaccine could arrive in the state as early as mid-December.
During a coronavirus press briefing Wednesday afternoon, the governor shared details on the state’s COVID-19 vaccination plans instead of implementing new statewide restrictions. Read More
The group of medical and public health experts that develops recommendations for vaccine use for the Centers for Disease and Prevention (CDC) will meet Tuesday.
CDC’s Advisory Committee on Immunization Practices (ACIP) posted a notice for a meeting scheduled for Dec. 1 without any details, but officials confirmed Friday that COVID-19 vaccination would be on the agenda. Read More
Tennessee is on target to receive doses of a COVID-19 vaccine for about 40,000 people by mid-December, state officials said Tuesday.
Tennessee Department of Health Commissioner Lisa Piercey said during a news briefing at the state Capitol that officials learned Monday the first doses are on track to be delivered by Dec 15. Read More
Many states in the U.S. are hinging their COVID-19 mitigation strategies on the availability of a widely available vaccine. An issue bound to arise is the extremely cold temperatures the most promising experimental vaccines need to be kept at and the logistics of delivering them across the country.
Moderna’s COVID-19 vaccine is estimated to remain stable at standard refrigerator temperatures of 36° to 46°F for 30 days. Longer storage means a required temperature of mRNA-1273 needs -4°F for up to six months. Read More
Pfizer said Wednesday that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to seek emergency use of limited shot supplies as the catastrophic outbreak worsens across the globe. Read More
Tennessee is one of four states chosen by pharmaceutical giant Pfizer to help refine plans for the delivery and deployment of the Pfizer-BioNTech COVID-19 vaccine if it receives approval from the U.S. Food and Drug Administration, Pfizer announced Tuesday.
The pilot program will help support states’ planning, deployment and administration of the COVID-19 vaccine and adapt findings for use in other states to support vaccine distribution. Tennessee released its COVID-19 vaccine distribution plan last month. Read More
In an interview with WMAL radio show Wednesday morning, Health and Human Services Secretary Alex Azar appeared to confirm that the Trump administration learned of Pfizer’s successful COVID-19 vaccine trial from press coverage not from company officials directly. “I…learned of this from media reports on Monday morning,” Azar told “Mornings on the Mall” program on November 11. “There certainly was a gap in communications, let’s say.” Read More
COLUMBUS, Ohio – Governor Mike DeWine made time during Wednesday night’s special broadcast to laud Pfizer and their progress on a coronavirus vaccine before effectively re-instating a mandatory mask mandate across the state. “On Monday, our country received some very promising news regarding a Coronavirus vaccine that Pfizer is… Read More
As the coronavirus pandemic swept across the globe in the spring, President Trump announced his plan to fast-track an effective vaccine that would be available by the new year.
The goal of Operation Warp Speed, launched by the White House in May, was “to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by January 2021, as part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.” Congress appropriated $10 billion to fund the ambitious program. Read More
The federal government pledged $1.95 billion for an order of up to 600 million doses of a coronavirus vaccine, which is set to enter key large-scale trials in the coming weeks. The average cost of a dose based on this deal is $3.25.
American pharmaceutical company Pfizer and German partner BioNTech announced the deal in a press release Wednesday. The companies are on track to produce 100 million doses by the end of the year and potentially 1.3 billion doses by 2022. Read More